Control of Gastric Acid with High Dose H2‐Receptor Antagonists after Omeprazole Failure: Report of Two Cases

The American Journal of Gastroenterology

Volumn 90, Issue 10, 1995, Pages 1874-1877

  Leite, Louis P ^a,b   Just, Robert J ^a,b   Castell, Donald O ^a,b   Lagerstrom P O ^a,b  

^a GRADUATE HOSPITAL   (United States)

^b Astra Hässle Co ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; NIZATIDINE; OMEPRAZOLE;

ADULT; ARTICLE; CASE REPORT; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SCREENING; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; MALE; PRIORITY JOURNAL; STOMACH ACID SECRETION; STOMACH PH;

ADULT; ANTI-ULCER AGENTS; CASE REPORT; CIMETIDINE; DRUG RESISTANCE; FEMALE; GASTRIC ACID; GASTROESOPHAGEAL REFLUX; HISTAMINE H2 ANTAGONISTS; HUMAN; MALE; NIZATIDINE; OMEPRAZOLE;

EID: 0029050255     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1995.tb08090.x     Document Type: Article

References (27)

1. Combined gastric and oesophageal 24‐hour pH monitoring and oesophageal manometry in patients with reflux disease resistant to treatment with omeprazole
2. Omeprazole resistance in patients with gastroesophageal reflux
3. 2 antagonist and omeprzole non‐responders
4. Physiologic distal esophageal acid exposure on omeprazole 40 mg/day
5. The pharmacokinetics of single and repeated once‐daily doses of 10, 20. and 40 mg omeprazole as enteric coated granules
6. Duodenngastric reflux: Relationship to pH and importance in Barrett's esophagus
7. Clinical pharmacology of omcprazole
8. Omeprazole: Overview and opinion
9. The continuing development of gastric acid pump inhibitors
10. 24‐hour intragastric acidity and plasma gastrin during long term treatment with omeprazole or raniti‐dine in patients with reflux esophagitis
11. Omeprazole in the treatment of erosive esophagitis refractory to high dose cimetidine
12. Double blind comparison of omeprazole versus cimetidine in the treatment of symptomatic erosive reflux oesophagitis
13. Comparison of omeprazole and cimetidine in reflux oesophagitis: Symptomatic, endoscopic. and histological evaluations
14. Medical therapy of patients poorly responsive to H2‐receptor antagonist therapy
15. 2 receptor resistant reflux esophagitis
16. Therapy with omeprayole in patients with peptic ulcerations resistant to extended high dose ranitidine treatment
17. Prevention of relapse of reflux ocsophagitis after endoscopic healing: The efficacy and safety of omeprazole compared with ranitidine
18. Long term maintenance treatment of reflux esophagitis with omeprazole. Prospective study in patients with H2‐blocker‐resistant esophagitis
19. Comparison of omeprazole and famotidine on esophageal pH in patients with moderate to severe esophagitis: A cross‐over study
20. Comparison of omeprazole and ranitidine in treatment of refractory gastroesophageal reflux disease in patients with gastric acid hypersecretion
21. Prospective evaluation of omeprazole treatment in reflux esophagitis refractory to H2‐receptor antagonists
22. Omeprazole in the treatment of peptic ulcers resistant to H2‐receptor antagonists
23. Omeprazole and ranitidine in the treatment of refractory reflux esophagitis
24. Omeprazole, serum gastrin, and gastric acid suppression
25. Evidence for abnormal proton pump as a mechanism for omeprazole resistance in patients with gastroesophageal reflux disease
26. Is there any acid peptic disease that is refractory to proton pump inhibitors
27. Long term treatment with omeprazole for refractory reflux esophagitis: Efficacy and safety